Skip to content
akaturk Academic measurement

Article detail · 2023 · article

Phenotypic and functional characterization of subpopulation of Imatinib resistant chronic myeloid leukemia cell line

Journal Adv Med Sci. The ISSN points to another catalog journal; the name is from the YÖKSİS record.
ISSN1896-1126
YÖKSİS OpenAlex
Year2023
Citations5OpenAlex
Percentile%74.2
FWCI0.91.00 = world average
Scopus (SJR)Q2
WoS (JCR)Q3

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueAdv Med Sci.
  • Catalog match (ISSN)Advances in Medical Sciences
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

5citationsOpenAlex · cited_by_count (cache / database)

11 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2024 Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemiaCitations 14 · OpenAlex
  2. 2024 Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemiaCitations 14 · OpenAlex
  3. 2024 Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemiaCitations 14 · OpenAlex
  4. 2024 Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemiaCitations 14 · OpenAlex
  5. 2024 Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemiaCitations 14 · OpenAlex
  6. 2025 Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia CellsCitations 0 · OpenAlex
  7. 2025 Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia CellsCitations 0 · OpenAlex
  8. 2025 Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia CellsCitations 0 · OpenAlex
  9. 2025 Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia CellsCitations 0 · OpenAlex
  10. 2024 P01-50 Mitochondria-specific targeting to overcome imatinib resistance in chronic myeloid leukemia cellsCitations 0 · OpenAlex

Authors

8
  1. YALDA HEKMATSHOAR 1
  2. AYNUR KARADAĞ GÜREL 2
  3. TÜLİN ÖZKAN 3
  4. YALDA RAHBAR SAADAT 4
  5. ASLI KOÇ 5
  6. ARZU ZEYNEP KARABAY 6
  7. SÜREYYA BOZKURT İSTİNYE ÜNİVERSİTESİ 7
  8. ASUMAN SUNGUROĞLU 8